Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M220Revenue $M5.7Net Margin (%)-817.7Altman Z-Score-14.7
Enterprise Value $M187EPS $-0.8Operating Margin %-976.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)-817.7Higher ROA y-yY
Price/Book14.010-y EBITDA Growth Rate %-38.0Quick Ratio2.6Cash flow > EarningsN
Price/Sales53.85-y EBITDA Growth Rate %-21.9Current Ratio2.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-71.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-247.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$2.1 - $2.83
($2.4)
$ 3.2335%Reduce 58.43%587,976
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 3.2357%New holding1,414,276
SNSSFirst Eagle Investment 2014-09-30 Sold Out $5.553 - $8.23
($6.91)
$ 3.23-53%Sold Out0
SNSSFirst Eagle Investment 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 3.23-36%New holding200,000
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 3.23-38%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 3.23-9%Reduce 30.24%350,000
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 3.2316%New holding501,727
SNSSFirst Eagle Investment 2009-12-31 Sold Out $1.8 - $12.54
($3.76)
$ 3.23-14%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$0.99 - $3.45
($1.95)
$ 3.2366%Reduce 90.60%16,667
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-59.47view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-59.47view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-59.47view
SANDELL SCOTT D10% Owner 2014-08-29Sell266,700$7.97-59.47view
KOLLURI KRISHNA KITTU10% Owner 2014-08-29Sell266,700$7.97-59.47view
KERINS PATRICK J10% Owner 2014-08-29Sell266,700$7.97-59.47view
DRANT RYAN D10% Owner 2014-08-29Sell266,700$7.97-59.47view
BASKETT FOREST10% Owner 2014-08-29Sell266,700$7.97-59.47view
BAY CITY CAPITAL LLC10% Owner 2014-08-28Sell300,700$7.98-59.52view
Misfeldt DaytonDirector, 10% Owner 2014-08-28Sell300,700$7.98-59.52view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
ciazek stock Mar 28 2015 
comment on SNSS Mar 02 2013 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
cooldecency99 note on SNSS May 01 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 

More From Other Websites
Sunesis to Present at Cantor Fitzgerald's Inaugural Healthcare Conference Jul 03 2015
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 8% - Tale of the Tape Jul 02 2015
Sunesis to Present at Cantor Fitzgerald's Inaugural Healthcare Conference Jul 01 2015
Sunesis (SNSS) Worth Watching: Stock Moves 9.1% Higher - Tale of the Tape Jun 23 2015
Sunesis Pharmaceuticals (SNSS) Shares March Higher, Can It Continue? - Tale of the Tape Jun 19 2015
These Biotech Stocks Could Deliver Big Returns for Investors Jun 15 2015
Edited Transcript of SNSS conference call or presentation 12-Jun-15 2:00pm GMT Jun 13 2015
How to Trade 5 of the Market's Most Active Stocks -- Buy, Hold or Sell? Jun 12 2015
Is Sunesis Coming Back From the Dead? Jun 12 2015
Sunesis Pharmaceuticals, Inc. Presentations of VALOR Data Call scheduled for 10:00 am ET today Jun 12 2015
Sunesis Pharmaceuticals Presents New Data From VALOR Evaluating Vosaroxin in Older Patients With... Jun 12 2015
Sunesis Pharmaceuticals Presents New Data From VALOR Evaluating Vosaroxin in Older Patients With... Jun 12 2015
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 10 2015
Sunesis Pharmaceuticals Announces Presentation of VALOR Trial Subgroup Analysis at ASCO 2015 Annual... May 31 2015
Sunesis Pharmaceuticals Announces Presentation of VALOR Trial Subgroup Analysis at ASCO 2015 Annual... May 31 2015
Sunesis Pharmaceuticals Announces Presentations of VALOR Data at the 20th Congress of the European... May 21 2015
Sunesis Pharmaceuticals Announces Presentations of VALOR Data at the 20th Congress of the European... May 21 2015
The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Update May 15 2015
Sunesis Pharmaceuticals Announces Presentation of VALOR Data at the 2015 ASCO Annual Meeting May 14 2015
Sunesis Pharmaceuticals Announces Presentation of VALOR Data at the 2015 ASCO Annual Meeting May 14 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK